According to research published in Nature last evening, eight antibodies are showing as effective in combating the coronavirus pathogens.
The most successful antibodies in fighting the virus and stopping its spread are SARS antibodies.
The study was conducted between scientists from Switzerland and the U.S., who isolated antibodies from a patient who survived SARS in 2003.
The pathogen that causes COVID-19 and SARS are both coronaviruses, which means they have a similar structure.
The antibody that showed the best results in actively eliminating the virus is known as S309.
When scientists combined S309 with less potent antibodies, they were able to attack the pathogen’s protein spike and neutralize it.
During the COVID-19 pandemic, we’ve seen different treatment trials, some even including antibodies from recovered patients.
However, the study that combines SARS antibodies with other antibodies aiming to defeat COVID-19 pathogens was never tested in humans, so it’s still early for celebration.
Nevertheless, this experiment is a step forward in fighting the pandemic and stopping its spread.
“These results pave the way for using S309- and S309-containing antibody cocktails for prophylaxis in individuals at high risk of exposure or as a post-exposure therapy to limit or treat severe disease,” they wrote.